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Abstract
Oxidative stress and mitochondrial function are at the core of many degenerative conditions. However, the interaction
between oxidative stress and in vivo mitochondrial function is unclear. We used both pharmacological (2 week paraquat
(PQ) treatment of wild type mice) and transgenic (mice lacking Cu, Zn-superoxide dismutase (SOD1
2/2)) models to test the
effect of oxidative stress on in vivo mitochondrial function in skeletal muscle. Magnetic resonance and optical spectroscopy
were used to measure mitochondrial ATP and oxygen fluxes and cell energetic state. In both models of oxidative stress,
coupling of oxidative phosphorylation was significantly lower (lower P/O) at rest in vivo in skeletal muscle and was dose-
dependent in the PQ model. Despite this reduction in efficiency, in vivo mitochondrial phosphorylation capacity (ATPmax)
was maintained in both models, and ex vivo mitochondrial respiration in permeabilized muscle fibers was unchanged
following PQ treatment. In association with the reduced P/O, PQ treatment led to a dose-dependent reduction in PCr/ATP
ratio and increased phosphorylation of AMPK. These results indicate that oxidative stress uncouples oxidative
phosphorylation in vivo and results in energetic stress in the absence of defects in the mitochondrial electron transport
chain.
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Introduction
Oxidative stress and mitochondrial function are key elements of
many pathological conditions, including high fat diet induced
insulin resistance, neurodegenerative disease, disuse atrophy, and
sarcopenia [1,2,3,4,5]. The role of reactive oxygen species (ROS)
in cellular function is most commonly associated with damage to
DNA, proteins, and lipids. However, ROS are also involved in the
regulation of several cellular processes including mitochondrial
biogenesis [6,7], increased activation of antioxidant defenses
[8,9,10], exercise adaptation in skeletal muscle [6,11,12,13] and
cell death [14,15]. Mitochondrial function and energy homeostasis
play a key role in many of these processes. Thus, interaction
between mitochondrial function and oxidative stress appears to
play an important role in controlling cell health and disease
[14,16,17,18]. However, the control of in vivo mitochondrial
function and cell energetics by oxidative stress remains unclear.
In skeletal muscle, ROS are produced by the mitochondrial
electron transport chain as a by-product of oxygen consumption
[19] and by cytosolic sources such as NAD(P)H oxidase during
contraction [12]. ROS or oxidative by-products modulate
mitochondrial metabolism in vitro beyond the mitochondrial
dysfunction that results from oxidative damage. Addition of
oxidants or lipid peroxides to isolated mitochondria results in an
increased proton leak from the inner membrane space into the
matrix thereby partially uncoupling mitochondrial ATP produc-
tion from oxygen consumption [20,21]. Rather than being caused
by damage to mitochondrial proteins or lipids, this reduced
coupling is the result of activated proton leak proposed to be
mediated by uncoupling protein 3 (UCP3) and adenine nucleotide
translocase (ANT) [22]. However, activated leak through UCP3
and ANT is enhanced in the presence of fatty acids and is
inhibited by physiological concentrations of GDP and other purine
nucleotides in vitro [22,23]. Thus, it is not clear to what extent this
oxidative stress-activated leak occurs in vivo and, if present, what
effect it has on cell energetics.
In this study we use metabolic spectroscopy to test the control of
in vivo mitochondrial coupling by oxidative stress. We use magnetic
resonance (MR) spectroscopy and optical spectroscopy [24] to
determine the coupling of oxidative phosphorylation (P/O),
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e26963maximal mitochondrial ATP production (ATPmax), and cell
energy state in mice treated with paraquat (PQ) and mice lacking
the antioxidant enzyme Cu-Zn-superoxide dismutase (SOD1
2/2).
We find that mild oxidative stress results in reduced P/O and
energy stress in vivo in mouse skeletal muscle before the
development of intrinsic mitochondrial defects.
Results
PQ treatment leads to oxidative stress in skeletal muscle
We used MR and optical spectroscopy to measure the effect of
increased oxidative stress on in vivo mitochondrial function in
skeletal muscle. Representative
31P MR and optical spectra of the
mouse hindlimb during rest and at the end of ischemia are
illustrated in Fig. 1. MR spectra of skeletal muscle reveal the
decrease in phosphocreatine (PCr) during ischemia while ATP
levels remain constant (Fig. 1A). Optical spectra become broader
with a more pronounced peak at 760 nm as hemoglobin and
myoglobin transition from their oxygenated to deoxygenated states
during ischemia (Fig. 1B). Table 1 lists resting levels for key
metabolites used to determine in vivo mitochondrial fluxes.
To better understand the effect of short term oxidative stress we
treated wild-type C57Bl/6J mice with low doses of PQ to induce a
mild oxidative stress. Mice were injected either once (PQ1) or
twice (PQ2) a week for two weeks with 10 mg PQ/kg body weight,
while controls (C) received volume-matched doses of saline. We
measured F2-isoprostanes in skeletal muscle of the hindlimb as a
marker of oxidative stress. Figure 2 shows that PQ treatment
induced a significant, dose-dependent oxidative stress in skeletal
muscle. We also observed significant differences in body weight in
both PQ1 (0.3%61.2% decrease, p,0.05) and PQ2 (2.9%61.2%
decrease, p,0.01) over the course of treatment relative to controls
(5.8%62.6% increase). To ensure that our measurements of in vivo
mitochondrial function were not affected by systemic effects of PQ
treatment on the cardiovascular system we measured resting heart
rate and arterial oxygen saturation in anesthetized mice (Methods
S1) and found no effect of PQ treatment on these parameters (Fig.
S1).
Reduced P/O and energy stress with PQ treatment
Resting in vivo mitochondrial oxygen consumption in the
hindlimb skeletal muscle increased significantly with PQ treatment
(Fig. 3A and 3B). In addition, resting in vivo myoglobin saturation
was negatively correlated with oxygen consumption due to the
increased oxygen demand of the muscle (Fig. S2). However, the
resting rate of mitochondrial ATP production was unchanged
Figure 1. In vivo spectra exhibit distinct differences under resting and ischemic conditions. (A) MR spectra collected during rest (top) and
after 10 min of ischemia (bottom). (B) Optical spectra collected at rest (top) and after 6 min of ischemia (bottom).
doi:10.1371/journal.pone.0026963.g001
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O ratio (ATP production/O2 consumption divided by 2) with PQ
treatment (Figs. 3E and S3A).
To measure the effect of increased oxidative stress on the
functional capacity of mitochondria we determined in vivo
ATPmax by measuring the rate of recovery of PCr from ischemia
in the mouse hindlimb [25]. Despite the reduction in P/O ratio,
ATPmax was not different between groups (Fig. 4).
Biochemical and molecular evidence indicates that PQ treatment
disrupted energy homeostasis in vivo in skeletal muscle. The PCr/
ATP ratio in resting skeletal muscle declined in a dose-dependent
manner with increasing PQ treatment (Fig. 5A and S3B). This
decrease in PCr/ATP led to a trend toward elevated AMP
concentrations in both treated groups (C: 104.4 nM616.1 nM,
PQ1: 156.7 nM648.0 nM, PQ2: 174.5 nM638.3 nM). Further
evidence that PQ treatment led to a disruption in energy
homeostasis comes from increased phosphorylation of the cell
energy sensing protein, 59 AMP-activated protein kinase(AMPK) in
the PQ2 group relative to controls (Fig. 5B).
Mild PQ treatment does not affect intrinsic mitochondrial
function
To determine whether the reduction in in vivo P/O with PQ
treatment was due to changes intrinsic to the mitochondria or due
to interactions between mitochondria and the cellular environ-
ment (e.g. ROS) we measured mitochondrial respiration in
permeabilized muscle fibers following in vivo studies. We found
no effect of PQ treatment on proton leak driven respiration,
maximal ADP stimulated respiration with complex I substrate
(state 3, complex I), maximal ADP stimulated respiration with
complex I and II substrates (state 3, complex I & II), uncoupled
respiration, uncoupled respiration with complex I inhibition (i.e.
complex II only), or complex IV respiration (Figs. 6A and 6B).
These results indicate that mitochondrial electron transport chain
function was not affected by this mild oxidative stress.
We next looked for changes in expression of genes and proteins
relevant to mitochondrial content and function in mixed
gastrocnemius to account for loss of in vivo P/O and maintenance
of mitochondrial capacity. We found no significant effect of PQ
treatment on gene expression of peroxisome proliferator-activated
receptor gamma coactivator 1- a (PGC1a), mitochondrial
transcription factor A (TFAM), the D-loop control region of
mitochondrial DNA (DCR), UCP3, or ANT1 (Fig. 7A). There was
also no difference in the content of the mitochondrial proteins
NDUFB8 of complex I, 30 kDa subunit of complex II, subunit IV
of cytochrome oxidase, UCP3, or ANT1 (Fig. 7B).
Oxidative stress leads to in vivo mitochondrial
uncoupling in SOD1
2/2 mice
As reported previously, the absence of SOD1 leads to increased
oxidative stress in mice [5]. We confirmed this finding as an
increase in F2-isoprostanes in skeletal muscle of SOD1
2/2 mice
(Fig. S4). While neither in vivo mitochondrial ATP production nor
oxygen consumption was significantly different in SOD1
2/2 mice
(data not shown), P/O ratio was significantly reduced (Fig. 8A). In
addition, resting ATP and total creatine concentrations were lower
in SOD1
2/2 mice compared to wild-type (WT) littermates
(Table 1).
Increased phosphorylation capacity in SOD1
2/2 skeletal
muscle
We found that ATPmax was significantly higher in mice lacking
SOD1 (Fig. 8B). This increase in ATPmax contrasts with the effect
of short term oxidative stress in PQ-treated mice and suggests a
compensatory increase in mitochondrial content with chronic
oxidative stress in SOD1
2/2 mice.
Elevation of electron transport chain complexes I, II, and IV in
the mixed gastrocnemius of SOD1
2/2 mice (Fig. 8C) was
associated with the increased ATPmax. DNA microarray analysis
of gene expression was used to further examine the mitochondrial
response to the absence of SOD1 (Methods S1, Tables S1 and S2).
Using NIH DAVID to examine the list of genes that were changed
Table 1. Metabolite concentrations in muscles of the mouse hindlimb.
Study Group PCr/ATP ATP(mM) Cr (mM) PCr (mM) Pi (mM) pHrest
PQ C 3.7760.04 9.5260.41 49.261.5 35.7760.36 2.5260.23 7.1160.03
PQ1 3.6260.06 10.4660.28 51.962.3 38.0260.65* 2.9960.31 7.0760.02
PQ2 3.5360.09* 9.8260.20 49.361.4 34.5660.88 3.0460.23 7.1360.02
SOD1 WT 3.6160.16 8.0060.92 41.162.6 28.9062.56 3.1160.17 7.0860.02
SOD1
2/2 3.8460.13 6.4860.80* 30.063.6* 25.5061.61* 3.7760.34 7.1460.03
ATP and total creatine (Cr) were determined using HPLC, and other values were calculated using MR spectra with ATP as an internal standard. All data are expressed as
mean 6 SEM. n=8–9 for PQ and n=4–5 for SOD1.
*p,0.05 relative to control.
doi:10.1371/journal.pone.0026963.t001
Figure 2. PQ-treatment caused a dose-dependent increase in
oxidative stress in mouse skeletal muscle. F2-isoprostanes
increased in skeletal muscle with PQ treatment. Data are expressed as
means 6 SEM with n=4–5 per group. (* p,0.05 and ** p,0.01 relative
to control).
doi:10.1371/journal.pone.0026963.g002
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2/2 mice
compared to WT we found that many genes involved in metabolic
processes or mitochondria were significantly upregulated, while
genes involved in the nuclear compartment and transcriptional
and translational processing were significantly downregulated (Fig.
S5).
Figure 3. The effects of PQ treatment on in vivo mitochondrial metabolism. PQ led to a significant, dose-dependent increase in oxygen
consumption (A and B; pre-oxygen limited slope of A used to calculate values represented in B) but had only a minor effect on resting ATP
production (ATPase) rate (C and D; slope of C used to calculate values represented in D). The ratio of ATP produced per O2 consumed (P/O ratio) is
significantly decreased in a dose-dependent manner with PQ treatment (E). Data are expressed as means 6 SEM with n=8–9 per group. (* p,0.05, **
p,0.01 relative to control).
doi:10.1371/journal.pone.0026963.g003
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of PQ, although the decrease in ATPmax of group PQ2 trended down (p,0.1). Data are expressed as means 6 SEM with n=8–9 per group. (* p,0.05
relative to control).
doi:10.1371/journal.pone.0026963.g004
Figure 5. PQ-treatment causes energy stress in vivo and activates energy sensing pathways. PCr/ATP ratio decreases with PQ treatment
(A, with representative MR spectra above) and the ratio of phosphorylated AMPK to total AMPK increased (B, with representative western blot above).
Data are expressed as means 6 SEM with n=5–9 per group. AMPK data are normalized to control average. (* p,0.05 relative to control).
doi:10.1371/journal.pone.0026963.g005
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We demonstrate that mild oxidative stress induced by either PQ
treatment or SOD1 knockout reduces the coupling of oxidative
phosphorylation in vivo and disrupts skeletal muscle energetics.
These results provide an in vivo test of the ‘‘uncoupling to survive’’
hypothesis, which proposes that oxidative stress activates mito-
chondrial proton leak and reduces the coupling of oxidative
phosphorylation [26]. Production of both ATP and ROS are
linked to the inner mitochondrial membrane potential (Dy), which
is generated as protons are pumped from the matrix to the inner
membrane space by the oxygen-consuming redox reactions of the
electron transport chain [27,28]. The ‘‘uncoupling to survive’’
hypothesis suggests that oxidative stress leads to an increase in
mitochondrial proton leak, and therefore a reduction of Dy,a sa
negative-feedback mechanism that mitigates further production of
mitochondrial ROS [19]. As a result of this proton leak, the
F1F0ATPsynthase is bypassed and the net result is a reduction in
the ATP produced per oxygen consumed (lower P/O).
In vivo P/O values were significantly reduced in both short-term
(2 week PQ treatment) and chronic (SOD1
2/2) models. The
10 mg/kg of PQ administered once or twice per week in this study
was sufficient to induce an increase in markers of oxidative stress,
but this PQ dose is well below the LD50 of 70 mg/kg reported for
mice when PQ is dissolved in saline and administered intraper-
itoneally [29]. Thus the absence of an acute effect on oxygen
delivery to skeletal muscle or severe mitochondrial dysfunction is
not surprising. Instead we observed a significant control of
mitochondrial metabolism and energetics. Resting mitochondrial
ATP production rate fluctuated less than 15% with PQ treatment
indicating that this level of oxidative stress did not greatly alter
resting ATP demand of skeletal muscle. However, oxygen
consumption increased by 43% in PQ1 and 71% in PQ2 to meet
this unchanged ATP demand as a result of the reduced coupling of
oxidation to phosphorylation. These results are similar to those
from isolated mitochondria and cells, where increased proton leak
can be induced by adding exogenous oxidants to the assay [21,30].
We used permeabilized muscle fibers to test whether the in vivo
effects on mitochondrial function were due to changes intrinsic to
the mitochondria or were the result of the interaction between the
mitochondria and the cellular environment. No difference in
mitochondrial respiration in permeabilized EDL between the PQ-
treated and control groups, including proton leak driven
Figure 6. PQ-treatment had no effect on ex vivo respiration of permeabilized EDL. (A) We detected no difference in leak driven respiration
between control and PQ2 in the permeabilized EDL. (B) State 3 with complex I substrate (‘‘CI’’), state 3 with complex I and II substrates (‘‘CI&II’’),
uncoupled (‘‘Uncoup’’), uncoupled with complex I inhibition (‘‘CII’’), and complex IV (‘‘CIV’’) respiration were also unchanged in group PQ2. Data are
expressed as means 6 SEM with n=5 per group.
doi:10.1371/journal.pone.0026963.g006
Figure 7. PQ treatment did not alter mitochondrial content or
composition. (A) We detected no differences between control and
PQ2 in gene expression of mitochondrial regulators PGC1a and TFAM,
the d-loop control region of mitochondrial DNA (DCR), UCP3, or ANT1.
(B) We also did not detect changes in protein expression of complexes I,
II, or IV, UCP3, or ANT1 in PQ2 animals. Data are expressed as means 6
SEM, normalized to control averages. n=5 per group.
doi:10.1371/journal.pone.0026963.g007
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was not due to oxidative damage or a change in the composition of
the mitochondria. These changes would be intrinsic to the
mitochondria and persist after the fibers were permeabilized and
the cell environment was replaced by respiration buffer. Further,
analysis of gene and protein expression in mixed gastrocnemius
revealed no differences in regulators of mitochondrial biogenesis
(PGC1a and TFAM), mitochondrial content (DCR and complex-
es I, II, and IV), or mitochondrial uncouplers (UCP3 and ANT1)
in PQ-treated mice. Therefore, we conclude that the reduced in
vivo P/O is due to direct control of mitochondrial function by ROS
or a related by-product.
Reduced in vivo coupling with PQ was not due to an
upregulation of UCP3 or ANT1 expression in the muscle. The
difference between our results and previous reports indicating that
UCP3 and ANT1 are upregulated in response to oxidative stress
may be due to differences in the magnitude of the oxidative stress
or the short duration of the treatment. The previous studies in cell
culture measured expression levels hours following an acute, high
dose oxidative stress [8], while the PQ treatment employed in this
study involved a relatively low level of stress induced over a period
of two weeks. The lack of difference in expression levels of UCP3
and ANT1 does not preclude a role for these proteins in the
reduced mitochondrial P/O in vivo. Activation of UCP3 or ANT1
mediated proton leak by oxidative stress or lipid peroxides
[20,21,31] in vivo provides a potential mechanism to explain the
difference between our in vivo and permeabilized fiber results.
Exchange of the cell environment and loss of potential activators of
UCP3 or ANT1 during the permeabilization process would
reverse the increased proton leak measured in vivo with PQ
treatment.
Chronic oxidative stress due to the absence of SOD1 also
reduced the efficiency of oxidative phosphorylation. In previous
studies, respiratory control ratios (state 3/state 4 respiration) in
isolated mitochondria were significantly reduced in 20 month old
SOD1
2/2 mice, associated with decreased mitochondrial ATP
production, loss of skeletal muscle mass, and increased mitochon-
drial H2O2 production [5,32]. In this study, the elevated ATPmax
and increased expression of mitochondrial proteins and transcripts
in SOD1
2/2 mice suggests that oxidative stress and uncoupling in
young adult SOD1
2/2 mice induce a compensatory increase in
mitochondrial capacity. The more severe effects on mitochondrial
dysfunction reported in SOD1
2/2 mice at older ages are likely
due to accumulation of oxidative damage to mitochondria and
decline in ATP produced per mitochondria [32]. The increase in
mitochondrial proteins in SOD1
2/2 mice is supported by the
growing evidence that ROS are important regulators of mito-
chondrial biogenesis. Treatment of renal proximal tubular cells
and neural cells with H2O2 in culture induces mitochondrial
biogenesis and upregulation of mitochondrial antioxidants [7,8].
The absence of an effect of PQ treatment on mitochondrial
biogenesis in this study may be due low level or short duration of
the stress.
Reduced P/O is associated with disruption of energy homeo-
stasis as indicated by the lower PCr/ATP ratios in PQ treated
mice. The mitochondrial membrane potential provides a mech-
anistic link between cell energy state and the coupling of oxidative
phosphorylation and imposes a thermodynamic limit on the ATP/
Figure 8. In vivo mitochondrial metabolism in SOD1
2/2 mice. (A)
Coupling of oxidative phosphorylation was lower in SOD1
2/2 mice, as
reflected by a significant decrease in P/O. (B) Despite this loss of
efficiency, ATPmax was higher in SOD1
2/2 mice. (C) Protein expression
of complexes I, II, and IV was also significantly higher in SOD1
2/2 mice.
Data are expressed as means 6 SEM with n=4–5 per group. In C, data
are normalized to control averages. Significant effect of genotype
determined by two-way ANOVA. (* p,0.05).
doi:10.1371/journal.pone.0026963.g008
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membrane potential decreases due to the increased proton leak
across the inner mitochondrial membrane, the resting ATP/ADP
ratio also decreases leading to a lower PCr/ATP and elevated
AMP levels through the creatine kinase and adenylate kinase
reactions [34]. Thus we find that mild oxidative stress is associated
with increased energy stress and elevated resting oxygen
consumption in resting skeletal muscle.
Although PCr/ATP ratio was maintainedinSOD1
2/2 mice,the
significant decrease in ATP concentration provides evidence of
energy stress in the case of chronic oxidative stress. We have
previously reported a loss ofrestingATPlevels in vivo associated with
reduced P/O in aged skeletal muscle from both mouse [35] and
humans [36]. However, we cannot ruleout the possibility that lower
ATPconcentrationsareduetoheterogeneityofcell health andATP
concentration within the skeletal muscle of the hindlimb. Our in vivo
MR and HPLC measurements of ATP are taken over the entire
distal hindlimb, so we cannot account for local differences or loss of
ATP in severely damaged fibers. These types of variation may
reduce the volume averaged resting ATP levels and provide an
alternative explanation for the lower ATP in SOD1
2/2 mice.
Maintenance of cell energy homeostasis is an important
determinant of cell health and survival [37]. Thus energy stress
is a key adaptive signal that modifies gene and protein expression
through multiple energy sensing signaling molecules such as
AMPK and related kinases [38]. AMPK phosphorylation is
sensitive to the cell ATP/AMP ratio [39], which is biochemically
linked to the PCr/ATP ratio through the creatine kinase and
adenylate kinase reactions [40,41]. Activation of AMPK through
increased phosphorylation controls downstream pathways to
reduce energy use [42] and increase energy production [43] to
restore energy homeostasis [39,43]. However, increased activation
of AMPK has also been shown to contribute to increases in cell
death and muscle atrophy [44,45,46]. Therefore, an initial
adaptive response by the cell to restore energy homeostasis may
ultimately have pathological outcomes in the presence of a chronic
energy or oxidative stress.
In conclusion, we demonstrate that mild oxidative stress leads to
reduced mitochondrial coupling and cell energy stress in vivo. Thus
reduced in vivo P/O may provide a mechanism that links mild
oxidative stress to the activation of energy sensitive signaling
processes. We demonstrate that this mitochondrial uncoupling and
energy stress precedes severe defects in mitochondrial function or
impaired ATP production and may serve as an early biomarker for
disruption of normal mitochondrial function by oxidative stress.
Methods
Animals
This study was approved by the Institutional Animal Care and
Use Committee of the University of Washington under protocol
number 4130-01. Male and female wild type and SOD1
2/2 [5]
C57BL/6J mice between the ages of 4 and 8 months were housed
in an environment with a fixed temperature, exposed to a 12 hour
light/dark cycle, and allowed free access to standard mouse chow
until immediately prior to experimentation. Mice were anesthe-
tized using 5% (w/v) Avertin (1:1 tribromoethanol in tert-amyl
alcohol) in saline at a dose of 0.01 mL/gram of body weight. Body
temperature was maintained at 35 +/2 1uC using heated air, and
mice breathed 100% oxygen throughout experiments.
Paraquat Treatment
Paraquat (Item 36541, Sigma, St. Louis, MO) was dissolved in
saline and administered via intraperitoneal injections at a dose of
10 mg/kg of body weight. All mice received four injections over
the span of 14 days (on days 1, 5, 8, and 12) for doses of 20 mg/
kg/week (PQ2), 10 mg/kg/week (PQ1), or 0 mg/kg/week (C).
Group PQ2 received 10 mg/kg paraquat on all four injection
days. Group PQ1 received volume-matched doses of saline on
days 1 and 8 and 10 mg/kg paraquat on days 5 and 12. Group C
received volume-matched saline on all four injection days. In vivo
spectroscopy commenced two days after the final injection in all
cases.
MR Spectroscopy
Detailed methods for MR spectroscopy are described elsewhere
[24]. Briefly, anesthetized mice were secured horizontally in a
vertical bore magnet (7 Tesla, Oxford Instruments, Oxford, UK)
using flexible straps. The distal hindlimb was positioned within a
three-turn solenoidal RF coil tuned to
31P (121.65 MHz), with a
custom-built ischemia cuff positioned proximal to the coil. After
shimming the proton peak using tissue water, a high signal to noise
31P spectrum was acquired under fully relaxed conditions (32
acquisitions with a 25 s interpulse delay) to calculate the peak
areas of inorganic phosphate (Pi), PCr, and ATP. We then
collected 200 dynamic spectra (4 acquisitions per spectrum with a
1.5 s interpulse delay and a 45u flip angle for a time resolution of
6 s) during 2 min of rest, 11 min of ischemia, and 7 min of
recovery to monitor the change in PCr peak area over time. Fully
relaxed peak areas were calculated by integration of processed
spectra using VNMR software on a Varian Inova console. For
dynamic spectra, two consecutive spectra were summed to
increase signal-to-noise (reducing time resolution to 12 s) and
peak areas relative to a standard spectrum were determined using
the Fit to Standard algorithm [47].
Optical Spectroscopy
Detailed methods for optical spectroscopy are also available
elsewhere [24]. After MR spectroscopy, mice were allowed to
recover for 24 h and then re-anesthetized. Hindlimbs were shaved
using standard hair clippers and mice were positioned on a flat
horizontal surface with the distal portion of their hindlimbs
oriented between two fiber optic bundles just downstream of an
ischemia cuff. One bundle directed light from a quartz-tungsten
halogen light source (Newport/Spectra-Physics, Santa Clara, CA)
onto the hindlimb. Light transmitted through the hindlimb was
acquired by the second bundle and delivered to a spectrograph
(InSpectrum, Acton, Acton, MA). Optical spectra were acquired at
1 s intervals during 3 min of rest, 7 min of ischemia, and 10 min
of recovery. Intensity spectra were converted to optical densities
(OD) using a 1% intralipid reference. The second derivatives of
OD spectra were analyzed using a partial least-squares (PLS)
algorithm [48] to isolate the contributions to absorbance of
oxymyoglobin, myoglobin, oxyhemoglobin, and hemoglobin.
Ex Vivo Mitochondrial Respiration
Respiratory complex activities were measured by monitoring
the rate of oxygen consumption in the presence of complex-
specific substrates and inhibitors. Complex activity was measured
when ATP production was coupled through a functional
respiratory chain with oxygen as the final electron acceptor and
also measured in the presence of the proton ionophore
carbonylcyanide m-chlorophenylhydrazone (CCCP), providing
rates of maximal electron flux independent of the phosphorylation
systems. Freshly dissected, gently separated and permeabilized
(50 mg/ml saponin, 4uC, 40 min) EDL muscle fibers were stirred
at 25uC in a 2 ml vessel of an oxygen monitoring apparatus (O2k
system, Oroboros Instruments, Austria) and provided with
Oxidative Stress and In Vivo Mitochondrial P/O
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glutamate/5 mM pyruvate/2 mM malate, without ADP), state 3
with complex I substrate (previous conditions with 2.5 mM ADP),
state 3 with complex I and II substrate (previous conditions with
10 mM succinate), uncoupled (previous conditions with 2.5 mM
CCCP to measure maximal flux), uncoupled with complex I
inhibition (i.e. complex II only; previous conditions with 0.5 mM
rotenone), finally 2.5 mM antimycin A was added to measure the
contribution of non-mitochondrial oxygen consumption followed
by measurement of complex IV (0.5 mM N,N,N9,N9-tetramethyl-
r-phenylenediamine (TMPD), 2 mM ascorbate). Potassium cya-
nide (1 mM) was used to confirm complex IV-specific activity. The
amount of oxygen consumed was calculated by assuming the
oxygen solubility in media to be 0.920 and by calibrating initial
oxygen concentration in the buffer for each experiment and
correcting for pressure, temperature, and instrumental oxygen
consumption as described by Gnaiger et al. [49].
Tissue Preparation
Muscles from the distal hindlimb (gastrocnemius, soleus, EDL,
tibialis anterior) were dissected and flash-frozen in liquid nitrogen
prior to death. These frozen muscles were pulverized over liquid
nitrogen and mixed well to form a homogenous powder for F2-
isoprostane, metabolite, hemoglobin, and myoglobin analysis. The
gastrocnemius from the contralateral leg was dissected, frozen, and
pulverized in liquid nitrogen for other biochemical analyses.
Metabolite Concentration
Tissue concentrations of ATP and creatine were measured in
mixed muscle preparations including gastrocnemius and tibialis
muscle groups using HPLC (Waters, Milford, MA) following a
previously published protocol [50]. We combined the gastrocne-
mius and tibialis muscle groups because they represent the bulk of
the muscles measured in our in vivo experiments.
Protein Content
Ten to 20 mg of pulverized muscle (whole leg or gastrocnemius)
was homogenized in Cellytic MT (Item C3228, Sigma) with
0.015% (v/v) protease inhibitor (P8340, Sigma) and 1% (v/v)
phosphatase inhibitor (Item #78420, Thermo Scientific, Wal-
tham, MA) at a ratio of 1:25 (w/v). Homogenates were combined
at a 1:1 (v/v) ratio with Laemmli sample buffer (#161-0737, Bio-
Rad, Hercules, CA) with 350 mM DTT, brought to 95u for 8 min,
and then centrifuged at 13,000 RPM for 10 min. Supernatants
were used for the following analyses. Hemoglobin and Myoglobin:
Proteins were separated from mixed muscle homogenates using
SDS-PAGE, stained with Coomasie Brilliant Blue (Bio-Rad), and
imaged using a ChemiDoc imaging system (Bio-Rad). Hemoglobin
and myoglobin band densities were measured using ImageJ and
calibrated using hemoglobin and myoglobin standards that were
run simultaneously. Western Blots: Proteins were separated from
gastrocnemius samples using SDS-PAGE and transferred to
nitrocellulose membranes before blocking and immunoblotting
for selected proteins. For complex I subunit NDUFB8 (MS105,
Mitosciences, Eugene, OR), complex II subunit 30 kDa (MS203/
C1217, Mitosciences), complex IV subunit IV (MS407, Mitos-
ciences) and ANT1 (#9299, Santa Cruz Biotechnology, Santa
Cruz, CA), membranes were blocked overnight at 4uCi n5 %
NFDM, primary antibodies were diluted 1:1000 in 1% NFDM,
and HRP-conjugated secondary antibodies (#7072, Cell Signal-
ing, Danvers, MA) were diluted 1:20000 in 1% NFDM. Actin
(AB14128, Abcam, Cambridge, MA) was probed simultaneously
as an internal loading control. For UCP3 (AB3477, Abcam),
AMPK (#2532, Cell Signaling), and phospho-AMPK (#2535,
Cell Signaling), membranes were blocked for 1 hour at room
temperature in 3% BSA, primary antibodies were diluted 1:1000
in 1% BSA, and HRP-conjugated secondary antibodies (#7074,
Cell Signaling) were diluted 1:2500 in 1% BSA. a-Tubulin
(#2125, Cell Signaling) was probed simultaneously as an internal
loading control.
RT-PCR
RNA was extracted from liquid nitrogen pulverized gastrocne-
mius using the RNeasy Mini Kit (Qiagen, Valencia, CA) and
cDNA libraries were created using the Omniscript RT Kit
(Qiagen). Real time PCR was carried out using a Rotor-Gene
6000 (Corbett Research, Cambridge, UK). Primers were furnished
by Dr. Rong Tian (UW Mitochondria and Metabolism Center,
Seattle, WA) and analyses were performed using Rotor-Gene 6000
Series Software.
F2-Isoprostanes
F2-isoprostanes were determined using a stable isotope dilution
method with detection by gas chromatography/negative-ion
chemical ionization/mass spectrometry (GC-NICI-MS) as previ-
ously described [51]. Briefly, 100–200 mg of mixed muscle
powder was homogenized in ice-cold Folch solution (chloro-
form/methanol 2:1) containing 5 mg/100 ml butylatedhydrox-
ytoluene. Lipids were then extracted and chemically hydrolyzed
with 15% KOH. After acidification with HCl, a stable isotope, 8-
iso-prostaglandin F2a-d4 internal standard was added. Following
extraction using C-18 and silica Sep-Pac cartridges, the eluted
compounds were dried under nitrogen then converted to
pentafluororobenzyl esters and purified by thin-layer chromatog-
raphy. The purified F2-isoprostanes were derivatized to trimethy-
silyl ether derivatives then dissolved in undecane for quantification
by GC/MS. Negative ion chemical ionization MS was performed
by Agilent 6890 GC and Model 5975 MSD instruments with
selected ions monitored for [
2H4]15-F2a-IsoP internal standard
(m/z 573) and F2-IsoPs (m/z 569).
Calculations
A more detailed description of our calculations is available
elsewhere [24]. A brief overview is presented below.
MR Spectroscopy. PCr/ATP ratios from fully relaxed
spectra were multiplied by ATP concentrations from HPLC to
find resting in vivo PCr concentration. Using this as a reference, the
slope from Fit-to-Standard was converted to an absolute PCr
concentration for each spectrum. PCr breakdown over time was fit
using a least-squares linear approximation, and PCr recovery after
cuff release was fit using a least-squares monoexponential
approximation. These fits were used to calculate the resting
ATP synthesis rate and maximum ATP synthesis rate [25],
respectively. Intracellular pH and AMP concentrations were
calculated using methods described elsewhere [52,53].
Optical Spectroscopy. The oxygen saturation of myoglobin
from PLS was multiplied by absolute myoglobin concentration to
find moles of oxygen bound to myoglobin and used to calculate
total dissolved oxygen in the intracellular compartment using
known oxygen-myoglobin binding kinetics at 37uC [54]. An
analogous approach was used to calculate moles of oxygen bound
to hemoglobin and vascular dissolved oxygen using the oxygen
saturation of hemoglobin from PLS. Oxygen consumption during
ischemia was found using a least-squares linear approximation of
change in total tissue oxygen content over time [24]. All measures
of oxygen consumption were made before oxygen became limiting
to respiration as previously described [55].
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Statistical analyses were performed using Prism v5 (GraphPad,
La Jolla, CA). In cases where three groups were compared (i.e. C,
PQ1, and PQ2), one-way ANOVA was used to determine
significance and Dunnett’s post hoc test was used to determine
significance of individual treatment groups vs. control. In cases
where two groups were compared (i.e. PQ2 vs. C or SOD1
2/2 vs.
WT), two-tailed Student’s t-tests were conducted. In figure 8C,
two-way ANOVA was used to determine the effect of SOD1
knock-out on multiple electron transport chain complexes.
Supporting Information
Figure S1 Heart rate (A) and arterial hemoglobin oxygen
saturation (B) were measured before (0 days), after one week (7
days) and following two weeks of PQ treatment (14 days). There
was no significant effect of PQ treatment on either variable at any
time point. Data means6SEM, n=5.
(TIF)
Figure S2 (A) A significant decrease in resting myoglobin (Mb)
saturation with PQ treatment indicates an increased mitochondrial
demand on oxygen delivery systems with uncoupling. n =8–9, *
p,0.05. (B) There is a significant negative correlation between
resting myoglobin saturation and in vivo mitochondrial oxygen
consumption in PQ mice (p,0.0001).
(TIF)
Figure S3 Oxidative stress has the same effect on the in vivo
metabolism of male mice as female mice. Treatment with 20 mg/
kg PQ per week for two weeks leads to (A) decreased coupling of
oxidative phosphorylation as measured by P/O ratio and (B)
increased energy stress as measured by PCr/ATP ratio in male
mice. Data means6SEM, n=3, * p,0.05.
(TIF)
Figure S4 The absence of SOD1 leads to an increase in oxidative
stress in skeletal muscle, as measured by F2-Isoprostanes in the
gastrocnemius of female SOD1
2/2 mice. Data means6SEM,
n=4,*p,0.05. Significance determined using one-tailed t-test.
(TIF)
Figure S5 Functional classification of genes differentially
regulated in SOD1
2/2 mice. Bars show the percentage of genes
in the GO categories significantly overrepresented in the genes
over expressed (A) or under expressed (B) in SOD1
2/2 relative to
WT in the EDL muscle using the GO FAT categories in NIH
DAVID. Dark bars indicate categories associated with mitochon-
drial function. Array analysis used n=4 per group. All categories
listed are p,0.05.
(TIF)
Table S1 List of genes differentially expressed in the EDL of
SOD1
2/2 mice compared to WT. Genes are grouped into those
uregulated and downregulated in SOD1
2/2 and sorted by false
discovery rate adjusted p-value (fdr_p). All genes are p,0.05.
(XLS)
Table S2 NIH DAVID Functional classification of genes listed
in Table S1. GO categories containing more than five members
with p,0.05 are listed. All categories, including redundant
categories, are listed in the table. Data in the % column was
used to generate Figure S5.
(XLS)
Methods S1 Detailed explanation of methods used to acquire
data presented in Figures S1 and S5 and Tables S1 and S2.
(DOC)
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